Cargando…
Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction – MiHeart/AMI study
BACKGROUND: Myocardial infarction remains as a major cause of mortality worldwide and a high rate of survivors develop heart failure as a sequel, resulting in a high morbidity and elevated expenditures for health system resources. We have designed a multicenter trial to test for the efficacy of auto...
Autores principales: | Dohmann, Hans FR, Silva, Suzana A, Sousa, André LS, Braga, Alcione MS, Branco, Rodrigo VC, Haddad, Andréa F, Oliveira, Mônica A, Moreira, Rodrigo C, Tuche, Fabio AA, Peixoto, Cíntia M, Tura, Bernardo R, Borojevic, Radovan, Ribeiro, Jorge P, Nicolau, José C, Nóbrega, Antonio C, Carvalho, Antonio CC |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2486263/ https://www.ncbi.nlm.nih.gov/pubmed/18598362 http://dx.doi.org/10.1186/1745-6215-9-41 |
Ejemplares similares
-
Multicenter randomized trial of cell therapy in cardiopathies – MiHeart Study
por: Tura, Bernardo R, et al.
Publicado: (2007) -
Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size
por: Valls-Lacalle, Laura, et al.
Publicado: (2018) -
The association of sex-specific hormones with coronary artery plaque characteristics from Miami Heart (MiHeart) study
por: Kwapong, Yaa A., et al.
Publicado: (2023) -
Author Correction: Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size
por: Valls-Lacalle, Laura, et al.
Publicado: (2019) -
Five‐year follow‐up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE‐AMI trial
por: Mathur, Anthony, et al.
Publicado: (2022)